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Abstract 
 
Purpose:  This aim of this study was to investigate health care professionals’  
(HCPs) and service-users’ (SUs) attitudes towards different treatment options 
in an Early Intervention for Psychosis (EIP) service as well as the topical issue 
of offering choice over treatment. 
Methodology:  Seven service-users accessing an EIP service and nine HCPs 
completed qualitative surveys about treatment for psychosis. Data was 
analysed thematically. 
Findings: Both HCPs and SUs appeared to have a generally positive attitude 
to the range of interventions offered by the EIP service and SUs talked about 
the importance of all treatment options being explored. There was variation in 
attitudes towards SUs having choice over their treatment and a number of 
factors were identified as crucial in influencing attitudes including mental 
capacity, risk and level of engagement. 
Research limitations: Small sample size and recruitment from only one EIP 
service limits generalizability.  
Practical implications: HCPs working in EIP services should explore different 
treatment options fully with SUs but be aware that they may feel unable to 
make the decision themselves. Such discussions should be revisited 
throughout an individual’s care as ability to make informed choices may 
change over time. Continuing Professional Development and clinical 
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supervision should be used to help HCPs reflect on the choice agenda and 
the implications of this for clinical practice. 
Originality / value: Few studies have examined attitudes towards treatments 
for psychosis. This is an evolving and important clinical area that remains 
under researched. Recommendations for service-development, future 
research and clinical practice are made.  
 
Key words: Psychosis, CBT, Antipsychotics, Early Intervention, Service-
development 
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Background 
 
Early Intervention for Psychosis (EIP) services aim to identify and engage 
people with a first episode of psychosis as early as possible to ensure timely 
access to evidence-based interventions and increase the likelihood of 
symptomatic and functional recovery. The UK’s Access and Waiting Time 
Standards for Mental Health Services specify that more than 50 per cent of 
people experiencing a first episode of psychosis should be treated with a 
National Institute for Health and Care Excellence (NICE) approved care 
package within two weeks of referral (NHS England, 2015). NICE guidelines 
state that EIP services should aim to provide a full range of pharmacological, 
psychological, social, occupational and educational interventions to service-
users (SUs) and that oral antipsychotic medication should be offered in 
conjunction with psychological intervention for people with first episode 
psychosis (National Institute for Clinical Excellence, 2014). For those 
considered to be at increased risk of developing psychosis, psychological 
therapy without antipsychotic medication is recommended as the front line 
intervention.  
Best practice guidelines have also stressed the importance of working in 
collaboration with SUs and carers, taking into account their needs and 
preferences, and enabling individuals to make informed decisions about their 
treatment (National Institute for Clinical Excellence, 2011). Such shared 
decision-making has been associated with an increase in treatment adherence, 
concordance and satisfaction across a range of settings. For people with first 
episode psychosis, treatment decisions might include the decision to try a 
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psychological intervention, such as Cognitive Behavioural Therapy (CBT), 
without antipsychotic medication for which there is emerging evidence 
(Morrison et al., 2012a; Morrison et al., 2014). Further, despite SUs valuing the 
positive effect of medication on psychotic symptoms and psychosocial 
functioning (Morant et al., 2017), issues of non-compliance and aversive side 
effects are also well documented (for example, Lieberman et al., 2005; Foley 
and Morley, 2011). Taken together, this has led some to argue that clinicians 
need to “reappraise the assumption that antipsychotics must always be the first 
line treatment for people with psychosis” (pg.84) (Morrison et al., 2012b). 
In light of guidance emphasising the importance of involving SUs in treatment 
decisions, the emerging evidence-base for psychological interventions 
(Morrison et al., 2012a; Morrison et al., 2014) and concerns about antipsychotic 
medication, there seems to be a rationale for providing choice to SUs over their 
treatment for psychosis. Whilst the idea of shared decision-making and offering 
choice over treatment appears to be broadly accepted in mental health care, in 
practice it remains a complex issue.  
As offering choice is dependent on health care professionals (HCPs) perceiving 
this as a useful thing to do, ultimately HCPs’ attitudes will determine what is 
offered, how it is offered and optimism about prognosis. A number of studies 
have been conducted examining HCPs’ attitudes in this respect. Carter and 
colleagues investigated beliefs about the causes of psychosis in a mixed group 
of mental health professionals and how these related to their opinions on the 
helpfulness of different types of treatments (Carter et al., 2017a). Significant 
associations between aetiological beliefs and perceptions about the 
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helpfulness of different treatments were found. For example, a belief that 
antipsychotics were helpful was positively associated with biological causes 
and negatively associated with psychosocial causes and vice versa for 
psychological treatments. It therefore seems that causal explanations are 
associated with, and may influence, beliefs about treatment efficacy in 
professionals. This is an empirical question that needs investigation. 
Interestingly, this pattern of results was not replicated when SUs were asked to 
complete a similar set of questions. Whilst SUs had a preference for a 
psychosocial explanation for their difficulties this was not related to their 
perception of how helpful different treatments were (Carter et al., 2017b).  
Therefore, unlike HCPs, SUs formulation of their difficulties may not alter their 
beliefs about different types of treatments suggesting for example, that even if 
a patient holds a biological view of their illness, they may still be open to 
exploring psychological treatments. What remains unclear from the existing 
literature is whether HCPs’ beliefs about the causes of psychosis and 
effectiveness of treatments predict behavior in clinical practice and could pose 
a barrier to offering choice over treatments to SUs with psychosis. 
From a HCPs’ perspective, a number of others barriers to offering patients 
choice over their treatment have been identified in a recent qualitative study 
examining the process of prescribing antipsychotic medication. These factors 
included a patient’s lack of understanding of symptoms or recognition of illness, 
a perception that the patient prefers professionals to make the decision, the 
setting (i.e inpatient versus outpatient) and a concern that giving choice 
undermines professionalism and perceived competency (Harris et al., 2017). 
Despite this, generally professionals in this study viewed the process of 
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prescribing antidepressants to be as collaborative as it could be. This was in 
contrast to the majority of SUs and carers who were interviewed in the study 
who experienced the process as hostile, paternalistic and not incorporating 
their views. This suggests that there is difference in the experience of 
collaborative decision-making between professionals and SUs and carers. 
As well as investigating the extent to which HCPs’ attitudes are important in the 
choice agenda, it is essential that SUs' attitudes are also considered. Day and 
colleagues investigated the relationship between SUs attitudes toward 
antipsychotic treatment and adherence (Day et al., 2005). As well as confirming 
that attitudes toward treatment as well as insight predicted adherence to 
medication, they identified a number of variables that were important in forming 
SUs’ attitudes. These included therapeutic alliance, lack of coercion and 
involvement in treatment decisions. These results are supported by a recent 
qualitative study which found that perceived lack of involvement with decisions 
about commencing or changing antipsychotic treatment was associated with 
poor adherence (Yiesen et al., 2017). These studies therefore suggest that 
SUs’ attitudes are shaped in part by their interactions with HCPs which in turn 
may have an influence on their behaviour.  
Given the apparent importance of the relationship between HCPs and SUs, 
several studies have highlighted how the power imbalance between 
professionals and SUs can influence the process and experience of treatment 
decisions. One study found that generally SUs felt powerless to influence 
decisions about their medication and felt that choices were limited due to the 
nature of their illness and perspectives of other people (Morant et al., 2017). As 
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highlighted by Quirk and colleagues, if SUs feel coerced or feel that they have 
little real influence over their treatment, then the potential benefits of shared-
decision making are lost (Quirk et al., 2012).  
Further research into attitudes and experiences of treatments for psychosis is 
needed to help understand the barriers to shared decision-making and offering 
choice over treatment. Using a qualitative methodology, this pilot study aims of 
explore HCPs’ and SUs’ attitudes toward different treatment options for 
psychosis as well as the topical issue of offering choice over treatment to SUs 
in an EIP service. 
Method 
Setting 
The study was based in an EIP service located in an inner city locality and took 
place over a 7-month period commencing in June 2013. Consistent with an EIP 
model of care, the service provides care for people from the age of 14 years 
who are experiencing a first episode of psychosis, or where there are concerns 
that this may be developing. The service provides a range of interventions, 
based on NICE guidelines, which aim to facilitate recovery. At the time of 
conducting the study, the service had a caseload of around 75 SUs and the 
staff team consisted of a part-time clinical psychologist, a part-time staff grade 
psychiatrist, a support worker, three nurse prescribers, three nurses without 
prescribing rights, an occupational therapist and a psychology student.  
Participants 
HCPs 
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All team members working clinically within the EIP service during the study 
period were invited to take part. The survey was discussed and described at a 
team meeting before the study started.  
Service-Users 
SUs were invited to take part by a member of the EIP team if their case was 
currently open to the EIP service during the study period and the clinician 
involved in the case deemed it to be appropriate to approach the SU regarding 
the study. No exclusion criteria were applied.  
Procedure 
Survey Development 
Two surveys were created, one for HPCs and one for SUs. The surveys were 
divided into two sections; a section that elicited quantitative data, and a 
qualitative survey section1. Only the data drawn from the qualitative surveys will 
be reported here. Qualitative surveys are a relatively novel method for data 
collection. They have unique advantages for qualitative researchers including 
being a relatively cost-effective and efficient way of collecting data, providing 
increased anonymity for participants and addressing a range of types of 
research questions (IBraun and Clarke, 2013). Qualitative surveys are 
particularly useful when investigating sensitive topics and questions related to 
views/ perspectives and practices as was the case with this study. 
HCPs’ Survey 
                                                        
1  The survey proforma is available from the corresponding author.  
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Based on a review of the extant literature on treatment options for first episode 
psychosis, a draft survey was created for the team. A team member from the 
EIP service, who was not directly involved in the study, provided feedback on 
the draft survey and further revisions were made. The final survey had 13 
questions and broadly aimed to examine attitudes towards different treatments 
for SUs with psychosis and SUs being offered choice over treatment. Survey 
items included: ‘How much choice do you believe service-users should have 
over commencing antipsychotic treatment?’, ‘What methods do you routinely 
use to ensure informed choice and shared decision making occur before 
commencing antipsychotic treatment?’ and ‘Under what circumstances would 
you feel most confident about not recommending antipsychotic medication to 
service-users?’. Five items required participants to comment on whether they 
agreed with a particular statement (e.g., ‘How much do you agree with the 
following statement “All service-users with psychosis require antipsychotic 
medication in order to recover”’). The final two items asked about their 
awareness of recent research on treatments for psychosis and whether this 
research had influenced their clinical practice. After each question there was 
space for free text. Copies of the survey were provided to all team members 
and they were invited to complete all items.  
SUs’ Survey 
In order to develop the survey for SUs, a focus group was convened with four 
SUs who had been discharged from the service (Three males and one female). 
After the aims of the project were detailed, topics that the SUs deemed 
significant based on their experiences were discussed. At the end of the focus 
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group, the themes of the discussion were summarised. A draft survey was 
constructed by the researchers based on the themes and circulated to 
members of the focus group for feedback. Further modifications were then 
made. The final survey had a total of 15 questions that focused on the process 
and experience of being prescribed medication (where applicable) and general 
attitudes towards different types of treatments and having choice over 
treatment. Survey items included: ‘How much choice do you feel you had over 
which medications were prescribed?’, and ‘How much choice do you believe 
people with a first episode of psychosis should have over starting antipsychotic 
treatment?’. As with the HCP survey, five items required participants to 
comment on whether they agreed with a particular statement and there was 
space after each question for free text.  
The University of Bath gave ethical approval for the study before the SU focus 
groups took place. 
Data Collection 
Following an EIP staff team meeting, hard copies of the survey were provided 
to all attendees. All members were invited to complete the survey and return 
the completed survey to one of the named researchers. To ensure all members 
of the team received a copy of the survey, it was also circulated electronically. 
For SUs, information sheets about the project were given to team members for 
circulation to SUs. If the SUs provided consent, they were sent either an 
electronic or hard copy of the survey, depending on preference. Once the 
survey had been completed and returned, SUs were thanked and entered into 
a draw to win a gift voucher.  
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Data Analysis 
The primary researcher transcribed written feedback verbatim. Data was coded 
and analysed using NVivo software. The thematic analysis procedure 
described by Braun and Clarke was used (Braun and Clarke, 2006). The HCPs’ 
and SUs’ data were coded and analysed separately. All transcripts were read 
and re-read to aid familiarisation with the data. Key words or phrases were 
highlighted and used to develop initial codes. Codes were then compared and 
organised into potential overarching themes and subthemes. The analysis used 
an inductive approach meaning that the themes characterised participants’ 
experiences rather than coding for the specific research question. The 
provisional themes were then reviewed to check (a) the themes worked in 
relation to the coded extracts, and (b) the themes reflected the data set as a 
whole. At this stage, two independent researchers were given a randomly 
selected sample of the transcripts to code. One researcher coded three of the 
SU transcripts and the other coded four HCP transcripts. The independent 
researchers were psychologists who had previous experience in thematic 
analysis but were unfamiliar with the specific aims of the study to encourage 
data-driven analysis. There was close agreement in terms of codes applied to 
the text. 
 
Interpretation of the data and the conclusions drawn were made in a meeting 
between the authors. As two of the authors worked in an EIP service, it was 
particularly important that during this meeting the researchers were able to 
reflect on their positions in relation to the data and how this may influence their 
interpretation of the data.  Where possible the words used by participants were 
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included in the theme title. 
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Results 
HCPs 
Nine team members who were working clinically self-selected to participate; 
equating to an 82% response rate. Professions represented included nursing 
(n = 4), psychology (n = 2), occupational therapy (n = 1) and support work (n = 
1). One participant did not specify profession. Two of the nine participants 
stated that they had prescribing rights. The mean duration of time working in EI 
was 4.4 years (range = 9 months - 7 years 6 months).  
The coding scheme included six related overarching main themes. Each 
theme is presented and supported by verbatim excerpts. 
Attitudes towards different interventions 
All HCPs commented on their attitude towards antipsychotic treatment as well 
as other non-pharmacological approaches offered by the service. The majority 
of participants reflected on the effectiveness of antipsychotics generally. 
“I have seen medication work when other options have failed and vice versa 
but I would always offer medication as one option.” [HPC 6] 
 
Three HCPs commented more specifically on the effectiveness of 
antipsychotics in reducing distress so that other interventions could be 
accessed.  
“Sometimes get a sense that need to ‘calm things down’ or smooth out 
thinking to engage in other work.” [HPC 5] 
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“Antipsychotics are sedating. Sometimes this is really helpful to minimise 
distress so that psy [psychological] work can be effective. However, sedation 
can be achieved by short-term benzos.” [HPC 2] 
As well as recognising the effectiveness of antipsychotic medication, four 
HCPs recognised how well some SUs do without any medication. Specific 
benefits of psychological interventions were also identified.  
“I believe that some service-users can benefit from just challenging their 
beliefs and CBT, especially if they have had a short DUP [duration of 
untreated psychosis] and if there isn’t as much conviction behind their beliefs.” 
[HCP 8] 
However, there was a sense from three HCPs that psychological interventions 
were generally thought of as a second line intervention after medication.  
“The reality is that it [CBT] usually comes as second wave.” [HCP 1] 
“Medication is still the ‘default’ treatment for ‘psychosis’ –still sold as a more 
exact science re dopamine etc than actually is.” [HCP 5] 
Decision-making regarding treatment with medication  
HCPs identified that in some circumstances the decision-making regarding 
treatment with medication would be more led by the clinician, but other times 
it would be led by the SU. Related to this, two HCPs also highlighted that 
sometimes SUs do not want to make a choice. 
“Some people want to have us choose, some don’t. ” [HCP 9] 
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Five HCPs highlighted that informed choice was an essential part of the 
decision-making process. 
“Where they [SUs] have capacity, they should have 100% choice, but 
sometimes we think it [medication] is needed despite the service-user not 
being keen. If we can offer choice regarding an alternative to antipsychotics, 
that is ideal (e.g., benzos).” [HCP 5] 
“I don’t advise on medication but always promote the service users right to 
ask questions and research their medication if they wish.” [HCP 9] 
Factors influencing prescribing 
Eight HCPs commented on factors that influenced prescription of 
antipsychotic medication including the SUs’ capacity to make treatment-
decisions, the DUP, individual characteristics of the person and their 
presentation, the role of third parties, engagement with service and 
professional’s knowledge about the effectiveness of antipsychotic medication.  
“I think the DUP is the crucial bit- the longer the DUP the more likely it is that 
medication will be required.” [HCP 6] 
“If people will engage in other treatments – i.e. psy [psychological 
interventions], are supported well by family/friends, and are able to occupy 
themselves, not offering meds is a realistic option. For people who are unable 
/unwilling to the above it is not a realistic option to not offer meds.” [HCP 3] 
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Process of prescribing medication 
HCPs reflected on the process of introducing medications to SUs. Some 
suggested that certain HCPs, particularly those with prescribing rights, should 
undertake initial conversations with SUs regarding medication. However, one 
HCP commented on how some professionals introduced a more biological 
explanation of psychosis when discussing antipsychotics..  
“Medics often sell TREATING psychosis- like it is an underlying thing rather 
than a state of mind.” [HCP 5] 
Provision of services 
Five HCPs highlighted that the EIP service in which they worked offered a 
range of interventions, other than just medication, and that SUs are rarely 
offered just one type of intervention. However, some HCPs felt that a medical 
model, emphasising biological factors, still dominated in the service, which 
meant that the first line intervention was medication. In some cases, it was felt 
that this was necessary in order to make other interventions accessible. 
Conversely, one HCP attributed the order of interventions to ‘service-level 
factors’ although the nature of these was not expanded on.  
“EI research and team discussions ensure the team approach reflects varied 
interventions of which medication has its place.” [HCP 7] 
“Always advocating for CBT- some service level limitations re early detection 
stuff.“ [HCP 5] 
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Research influencing practice 
There was evidence that HCPs were aware of recent research on the 
effectiveness of antipsychotic medications and non-pharmacological 
interventions (with and without medication). However, a number of HCPs 
referred to limitations of using the research to guide practice including 
overstated effects, poor quality and employing inappropriate measures. 
“Research is poor, contradictory or badly interpreted. Also not measuring 
good quality med management.” [HCP 1] 
SUs 
Seven SUs out of eight approached took part (5 men, 2 women). The mean 
age of the SU was 26.1 years (age range = 22 - 39 years). Five SUs described 
themselves as White British, one as White Irish and one did not respond to this 
question. The mean length of time supported by the EIP service at the point of 
completing the survey was 33 months (range = 6 - 48 months). One of the SUs 
had their first contact with the EIP service following admission to hospital. All 
SUs reported that they had taken medication for psychosis; the majority had 
been prescribed antipsychotic medication (n = 6). All SUs who had been 
prescribed antipsychotic medication had also been prescribed at least one 
other type of medication including antidepressants (n = 3), anxiolytics (n = 3) or 
Z drugs (n = 2).  
The final coding scheme for SUs included six main themes.. Each theme is 
presented in the paragraphs that follow and supported by verbatim excerpts.  
 
 19 
Choice over treatment 
The majority of SUs commented on their attitude towards having choice over 
treatment, and more specifically, having input into decisions around starting or 
changing their medication regime. There seemed to be a divide in terms of 
whether SUs wanted choice over their treatment. Some were happy to follow 
whatever treatment was recommended, others felt they should have choice 
over their treatment but be guided towards a decision by HCPs. One SU felt 
strongly that they wanted medication and therefore they did not feel that there 
was a choice to be made.  
“I believe that people experiencing first episodes of psychosis should obviously 
have a choice in their treatment but also should be helped in the right direction.” 
[SU 1] 
“Totally wanted medication as I was sure it was best for the condition I thought 
I had.” [SU 5] 
“If feel that if the recipient has fairly good control over their mental state, they 
should be able to choose whether they go on drugs no matter their age or 
gender.” [SU 6] 
There was evidence from five SUs that they did have input into changes in their 
medication regime, both in terms of dose and type of drug, or felt able to 
contribute to such decisions should they want to.  
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“I remember being given the choice of switching from Olanzapine to 
Aripiprazole.” [SU 7] 
“If I felt I wanted to change or stop taking medication I would inform [Name of 
EIP worker] ASAP.” [SU 1] 
However, two SUs felt that they got what they were prescribed without having 
much input into the process. One SU said that they did not get on with the 
clinician who was prescribing them medication and felt as though they did not 
have any choice in seeing anyone else.  
 “I got prescribed what I was given.” [SU 2] 
“I didn’t like [HCP name] and had no choice in seeing others for meds”. [SU 6] 
 
Informed decision-making 
SUs talked about the different ways in which information about treatment 
options was provided to them. Methods mentioned included leaflets and 
discussion. However, there was evidence from two SUs that their mental state 
at the time made it difficult to process and understand the information that was 
provided.  
“At the time of starting meds I wouldn’t have had any capacity to read 
information.” [SU 2] 
“I was told it was a neuroleptic but I still don’t really know what it does.”  
[SU 4] 
Attitude towards taking medication 
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The majority of the SUs commented on their attitude towards taking medication 
for their symptoms. Some SUs felt strongly that medication was the best option; 
others felt it was best used in combination with other approaches, such as 
talking therapies.  
“I have a science background and I feel I am biased in favour of medication.” 
[SU 5] 
“The medication definitely helps when used in conjunction with other 
techniques e.g. CBT, psychology work.” [SU 7] 
A minority of SUs indicated that they were not in favour of medication. Reasons 
were given for this and included not finding that they alleviated the symptoms 
that they were experiencing and knowing that people can recover with other, 
non-drug treatments.  
 “Didn’t really want to take meds in first place and didn’t make much 
difference…some people can be alright with CBT or other means without 
drugs.” [SU 6].  
Others input into treatment decisions 
Three SUs commented on their experience of having family members or 
significant others involved in conversations around treatments. There was a 
split between those who thought this was helpful due to their mental state at 
the time, and others who felt that family members did not need as much input 
as they had.  
“I personally think they [family members/ significant others] didn’t need quite as 
much input.” [SU 7]  
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“One may not be thinking straight so may need to be persuaded to take 
medication until they feel well enough to make a reasonable choice.” [SU 5] 
Individualised treatment 
The majority of SUs identified various person and illness-related variables 
which should influence the treatment plan and determine whether an individual 
can have choice over their treatment. SUs talked about mental state, risk to self 
and others and insight. There was also reference to personal situations and 
circumstances influencing a person’s treatment.  
“I think it all depends on the personal situation and how that particular person 
is being affected.” [SU 1] 
“I thought I was in the FBI during my first episode of psychosis and I had no 
awareness at all. Should depend on how aware a person is.” [SU 5] 
Intervention in EIP services 
SUs highlighted that there are a range of different treatment options available 
in EIP services and that all possible options should be explored. Three SUs 
indicated that they believed that people can recover without medication and 
also that individuals may have their own ideas about what will help them.  
“I think people may have their own ideas on how to get better as well.” [SU 7] 
Two SUs commented on the order of different interventions, specifically 
whether medication should come before, after or at the same time as other 
approaches.  
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“From my experience with [Name of EIP worker] I believe the initial problem 
should be sourced before medication is prescribed.” [SU 1] 
“Don’t think psychological understanding is separate to using medication.” [SU 
4] 
Discussion 
The aim of this study was to examine the attitudes of SUs and HCPs towards 
treatment options for people with psychosis and crucially the issue of SUs 
having choice over their treatment in an EIP service. Both HCPs and SUs 
appeared to view the range of interventions offered by the EIP service as 
broadly acceptable and SUs talked about the importance of all treatment 
options being explored. A number of factors were identified as crucial in 
influencing HCPs’ and SUs’ attitudes towards SUs having choice over their 
treatment. Reservations about using research to guide practice were also 
raised by HCPs.  
 
Comparison of the current findings to other qualitative studies highlights similar 
themes. For example, Carrick and colleagues also found that the process of 
making decisions about treatment, as well as the treatment itself, need to be 
individualised as there are various factors which might influence how active a 
person can be in treatment decisions and also how much choice or control is 
‘enough’ for a given individual  (Carrick et al., 2004). Whilst SUs and HCPs in 
this study generally acknowledged the importance of SUs having choice over 
treatment, particularly medication, a number of variables were identified which 
influenced their perspectives including capacity, duration of untreated 
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psychosis, risk and engagement. Some HCPs felt that SUs should have choice 
over treatment if they retained capacity to do so and had adequate insight. 
However, capacity and insight are dynamic variables suggesting that the 
degree to which SUs are involved in treatment decisions should be re-
considered at different time points.  The data was mixed with regards to whether 
SUs felt that they had input into discussions around changing type of 
medication or the dose after medication had been prescribed. This finding is 
similar to that reported in a recent qualitative study with longer term SUs in 
which some participants reported feeling powerless to initiate conversations 
about changing their medication or lowering the dose even though they were 
not happy and wanted a change (Morant et al., 2017). Further, there is evidence 
that lack of involvement may reduce trust in professionals and adherence to 
medication (Yiesen et al., 2017). Therefore, a clear recommendation for clinical 
practice following on from these findings is that discussions about treatment 
options should be revisited by HCPs throughout a SUs involvement with EIP 
services. 
 
It will be important for future research to also investigate possible barriers to 
HCPs exploring all treatment options with SUs.  Studies have demonstrated 
that the explanatory framework employed by an individual regarding mental 
health influenced their views of treatment options and recovery from mental 
illness (Lam and Salkovskis, 2007; Lam, Salkovskis and Hogg, 2016).  More 
specifically in the context of psychosis, it has been shown that the aetiological 
model held by a professional is associated with beliefs about the efficacy of 
treatments for psychosis (Cater et al., 2017a). The results of the current study 
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suggested that SUs’ and HCPs’ attitudes on treatment options and choice may 
in part be influenced by the explanatory framework they have. This in turn, may 
be influenced by the psychoeducation HCPs provide for SUs or more general 
education about the causes of mental illness. For example, if a SU has a more 
biological understanding of their ‘mental illness’ they may be more likely to view 
medication as crucial. Similarly, if the HCP has a more psychological 
understanding of psychosis, they may have a more positive attitude towards 
offering CBT for psychosis without medication. It may also be important to 
consider whether wider cultural explanations of mental illness impact on SUs’ 
attitudes towards support and recovery (Larsen, 2004), although the current 
study does not specifically address this issue. Thus, it is possible that the 
explanatory framework either SUs or HCPs hold could influence attitudes 
towards different treatments. This may in turn affect the way in which different 
treatments are discussed and the order in which they are offered by the HCP 
or accepted by the SU. This is an area which warrants further investigation as 
these factors may act as one barrier to exploring all treatment options.  
 
The implementation of robust research findings into clinical practice is critical 
for increasing the overall standard of care for SUs and improving outcomes 
(Geddes and Harrison, 1997). Interestingly, HCPs indicated that they were 
aware of recent research in the field of treatment for psychosis, such as 
studies indicating that CBT may be effective for SUs who are medication 
naïve, yet for some, responses indicated that such research did not influence 
their attitudes. As more research is completed in this area, it will be important 
for HCPs’ knowledge of the evidence-base for different treatment options to 
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be updated regularly and barriers to integrating this knowledge into their 
clinical practice explored. Regular CPD as well as discussion of issues related 
to the choice agenda in supervision may aid this. Increasing clinicians’ 
knowledge base through these means may in turn contribute to attitudinal and 
behavioural change. 
 
Limitations 
Whilst the small homogenous sample and recruitment from one EIP service 
limits the generalizability of the data, the results suggest the value of extending 
this type of research to larger and more diverse samples from other EIP 
services. It was not possible to explore within group differences due to the size 
of the sample, for example whether attitudes differ depending on the profession 
or the explanatory framework of the HCP. Further research with a larger sample 
size may enable exploration of such questions. Lastly, due to the method of 
data collection used in this study (qualitative surveys), it was not possible to 
explore themes in further depth. This is a recognised limitation of the qualitative 
survey method.   
 
Future directions 
The attitudes of the HCPs reported in this study may not necessarily directly 
map onto clinical practice and so whether attitudes affect practice needs to be 
investigated. Similarly, it would be important to establish whether SUs’ attitudes 
towards treatment and their experience of being offered choice over treatment 
influences adherence to their treatment and other relevant clinical outcomes. 
Lastly, the study was conducted before the UK Access and Wait Times 
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standards were published. It would be interesting to repeat the study now that 
the standards have been implemented and assess whether increased staff 
training has been effective in changing HCPs’ attitudes and practices.  
 
Conclusions 
There is variation in SUs’ and HCPs’ attitudes towards treatments for psychosis 
and also their views on how much choice SUs should have over treatment. 
There are a number of factors that influence HCPs’ and SUs’ attitudes about 
treatments and choice. HCPs working in EIP services should explore different 
treatment options fully with SUs but be aware that they may feel unable to make 
the decision themselves. Such discussions should be revisited throughout an 
individual’s care as ability to make informed choices may change over time. 
The results of this pilot study have implications for further research in the area 
of attitudes towards treatments in psychosis and SUs having choice over 
treatment.  
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